help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, D. G.
Right arrow Articles by Grossman, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, D. G.
Right arrow Articles by Grossman, A. B.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 12 6080-6087
Copyright © 2003 by The Endocrine Society

Identification of Adrenocorticotropin Receptor Messenger Ribonucleic Acid in the Human Pituitary and Its Loss of Expression in Pituitary Adenomas

Damian G. Morris, Blerina Kola, Ninetta Borboli, Gregory A. Kaltsas, Maria Gueorguiev, Anne Marie McNicol, Roderick Ferrier, T. Hugh Jones, Stephanie Baldeweg, Michael Powell, Sándor Czirják, Zoltán Hanzély, Jan-Ove Johansson, Márta Korbonits and Ashley B. Grossman

Department of Endocrinology (D.G.M., B.K., N.B., G.A.K., M.G., M.K., A.B.G.), St. Bartholomew’s Hospital, London EC1A 7BE, United Kingdom; Division of Cancer Sciences and Molecular Pathology (A.M.M., R.F.), Medical Faculty, University of Glasgow, Glasgow G4 0SF, United Kingdom; Academic Unit of Endocrinology (T.H.J.), Division of Genomic Medicine, University of Sheffield, Sheffield S10 2RX, United Kingdom; National Institute of Neurology and Neurosurgery (S.B., M.P.), Queen Square, London WC1N 3BG, United Kingdom; National Institute of Neurosurgery (S.C., Z.H.), 1145 Budapest, Hungary; and Research Centre for Endocrinology and Metabolism (J.-O.J.), Sahlgrenska University Hospital, 413 45 Göteborg, Sweden

Address all correspondence and requests for reprints to: Professor A. B. Grossman, Endocrine Oncology, Department of Endocrinology, St. Bartholomew’s Hospital, London EC1A 7BE, United Kingdom. E-mail: a.b.grossman{at}qmul.ac.uk.

The ACTH receptor (ACTH-R) is the second member of the melanocortin (MC-2) receptor family that includes five seven-transmembrane G protein-coupled receptors and has been shown to be predominantly expressed in the adrenal cortex. It has been postulated that ACTH may regulate its own secretion through ultra-short-loop feedback within the pituitary. ACTH-secreting adenomas are characterized by resistance to glucocorticoid feedback, and they may have dysregulated ACTH feedback. We therefore investigated the ACTH-R in normal and adenomatous human pituitary tissue. We report here the identification of ACTH-R mRNA in the human pituitary gland, which was confirmed by direct sequencing. We studied the expression of the ACTH-R in 23 normal pituitary specimens and 53 pituitary adenomas (22 ACTH-secreting, nine GH-secreting, eight prolactin-secreting, one TSH-secreting, one FSH-secreting, 10 nonfunctioning, and two silent corticotroph adenomas), using the sensitive technique of real-time quantitative PCR. Contamination of ACTH-secreting adenomas and nonfunctioning pituitary adenomas with nonadenomatous tissue was excluded by lack of Pit-1 expression. ACTH-R mRNA was detected in all normal pituitary specimens, and in situ hybridization colocalized expression to ACTH staining cells only. However, ACTH-R mRNA levels were undetectable in 16 of 22 ACTH-secreting tumors and in both silent corticotroph tumors. Diagnostic preoperative plasma ACTH levels were significantly lower in the ACTH-R positive ACTH-secreting tumors, compared with those who were ACTH-R negative (P = 0.0006). Direct sequencing of the coding region of the ACTH-R in cDNA from three ACTH-secreting tumors positively expressing the receptor showed no mutations, as did sequencing of genomic DNA in three receptor negative ACTH-secreting tumors and the two silent corticotrophs. These results provide further evidence compatible with an ACTH feedback loop in the pituitary and suggest that loss of expression of the ACTH-R in corticotroph adenomas of patients with Cushing’s disease may play a role in the resistance to feedback of the pituitary-adrenal axis seen in these patients.

D.G.M. and M.G. were supported by the Joint Research Board of St. Bartholomew’s Hospital. B.K. was supported by the Cancer Research Committee of St. Bartholomew’s Hospital. M.K. is a Medical Research Council Clinical Scientist.

Abbreviations: ACTH-R, ACTH receptor; DIG, digoxigenin; dNTP, deoxynucleotide triphosphate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; gDNA, genomic DNA; ISH, in situ hybridization; NFPA, nonfunctioning pituitary adenoma; POMC, proopiomelanocortin; PRL, prolactin; RQ-PCR, real-time quantitative PCR; RT, reverse transcription; SSC, saline sodium citrate; UTR, untranslated region.




This article has been cited by other articles:


Home page
FASEB J.Home page
M. Doufexis, H. L. Storr, P. J. King, and A. J. L. Clark
Interaction of the melanocortin 2 receptor with nucleoporin 50: evidence for a novel pathway between a G-protein-coupled receptor and the nucleus
FASEB J, December 1, 2007; 21(14): 4095 - 4100.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
L. A Noon, A. Bakmanidis, A. J L Clark, P. J O'Shaughnessy, and P. J King
Identification of a novel melanocortin 2 receptor splice variant in murine adipocytes: implications for post-transcriptional control of expression during adipogenesis
J. Mol. Endocrinol., December 1, 2006; 37(3): 415 - 420.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. S. Woo, A. M. Isidori, W. Z. Wat, G. A. Kaltsas, F. Afshar, I. Sabin, P. J. Jenkins, J. P. Monson, G. M. Besser, and A. B. Grossman
Clinical and Biochemical Characteristics of Adrenocorticotropin-Secreting Macroadenomas
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4963 - 4969.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
D. G Morris, M. Musat, S. Czirjak, Z. Hanzely, D. M Lillington, M. Korbonits, and A. B Grossman
Differential gene expression in pituitary adenomas by oligonucleotide array analysis
Eur. J. Endocrinol., July 1, 2005; 153(1): 143 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Noon, A. J. L. Clark, and P. J. King
A Peroxisome Proliferator-response Element in the Murine mc2-r Promoter Regulates Its Transcriptional Activation during Differentiation of 3T3-L1 Adipocytes
J. Biol. Chem., May 28, 2004; 279(22): 22803 - 22808.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society